CUREONE Trademark

Trademark Overview

On Tuesday, June 27, 2017, a trademark application was filed for CUREONE with the United States Patent and Trademark Office. The USPTO has given the CUREONE trademark a serial number of 87506876. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, January 10, 2019. This trademark is owned by Molecular Evidence Development Consortium. The CUREONE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Hosting a web-based registry of laboratory data to advance disease technologies and develop treatments to improve the quality of care in patients with cancer and chronic diseases
cureone

General Information

Serial Number87506876
Word MarkCUREONE
Filing DateTuesday, June 27, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, January 10, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesHosting a web-based registry of laboratory data to advance disease technologies and develop treatments to improve the quality of care in patients with cancer and chronic diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 3, 2017
Primary Code042
First Use Anywhere DateFriday, June 2, 2017
First Use In Commerce DateFriday, June 2, 2017

Trademark Owner History

Party NameMolecular Evidence Development Consortium
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOwasso, OK 74055

Trademark Events

Event DateEvent Description
Thursday, January 10, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, January 10, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, June 18, 2018UNDELIVERABLE MAIL - COURTESY COPY MAILED
Thursday, June 14, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, June 14, 2018FINAL REFUSAL E-MAILED
Thursday, June 14, 2018FINAL REFUSAL WRITTEN
Wednesday, May 23, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 23, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 22, 2018ASSIGNED TO LIE
Tuesday, May 15, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 17, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 17, 2017NON-FINAL ACTION E-MAILED
Friday, November 17, 2017NON-FINAL ACTION WRITTEN
Friday, October 27, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 26, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 26, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 25, 2017PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, October 25, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, September 26, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 26, 2017NON-FINAL ACTION E-MAILED
Tuesday, September 26, 2017NON-FINAL ACTION WRITTEN
Monday, September 25, 2017ASSIGNED TO EXAMINER
Monday, July 3, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 30, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

cureone care quality improve patients cancer diseases chronic treatments develop laboratory